Metraipolis › archive › dc_ea0aeca47f14

Modified-release hydrocortisone (Efmody®) in children with congenital adrenal hyperplasia: a retrospective registry study — Europe PMC PMID:42483672

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42483672
DOI
10.3389/fendo.2026.1854737
License (as archived)
solo-consultazione
Archived
2026-10-18T10:38:24.536Z
SHA-256 of the archived text
8c0244e888bec18f3f40d4bf931f87b39b38a2ba6de73edf567e01d75f0e378d
Stable URL of this page
https://metraipolis.com/documento/dc_ea0aeca47f14

How to cite

Modified-release hydrocortisone (Efmody®) in children with congenital adrenal hyperplasia: a retrospective registry study — Europe PMC PMID:42483672 — Europe PMC (en), https://europepmc.org/article/MED/42483672 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea0aeca47f14 (Metraipolis archive dc_ea0aeca47f14, sha256 8c0244e888bec18f3f40d4bf931f87b39b38a2ba6de73edf567e01d75f0e378d)
BibTeX
@misc{dcea0aeca47f14,
  title = {Modified-release hydrocortisone (Efmody®) in children with congenital adrenal hyperplasia: a retrospective registry study — Europe PMC PMID:42483672},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42483672},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea0aeca47f14; sha256 8c0244e888bec18f3f40d4bf931f87b39b38a2ba6de73edf567e01d75f0e378d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42483672. Agents can read the archived copy with the MCP tool read_document.